CoreStock

Stock price

Market cap

At each fiscal year end, then the latest quarter end: closing price × shares outstanding.

Show table
Zoetis market cap, annual
PeriodMarket cap
FY2016, ended Dec 31, 2016$26.3B
FY2017, ended Dec 31, 2017$35.0B
FY2018, ended Dec 31, 2018$41.0B
FY2019, ended Dec 31, 2019$62.9B
FY2020, ended Dec 31, 2020$78.6B
FY2021, ended Dec 31, 2021$115B
FY2022, ended Dec 31, 2022$67.9B
FY2023, ended Dec 31, 2023$90.4B
FY2024, ended Dec 31, 2024$73.0B
FY2025, ended Dec 31, 2025$53.1B
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$29.7B

Revenue

By fiscal year, then the trailing 12 months

Show table
Zoetis revenue, annual
PeriodRevenue
FY2016, ended Dec 31, 2016$4.89B
FY2017, ended Dec 31, 2017$5.31B
FY2018, ended Dec 31, 2018$5.83B
FY2019, ended Dec 31, 2019$6.26B
FY2020, ended Dec 31, 2020$6.67B
FY2021, ended Dec 31, 2021$7.78B
FY2022, ended Dec 31, 2022$8.08B
FY2023, ended Dec 31, 2023$8.54B
FY2024, ended Dec 31, 2024$9.26B
FY2025, ended Dec 31, 2025$9.47B
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$9.53B

Net income and free cash flow

By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.

Show table
Zoetis net income and free cash flow, annual
PeriodNet incomeFree cash flow
FY2016, ended Dec 31, 2016$821M$497M
FY2017, ended Dec 31, 2017$864M$1.12B
FY2018, ended Dec 31, 2018$1.43B$1.45B
FY2019, ended Dec 31, 2019$1.50B$1.33B
FY2020, ended Dec 31, 2020$1.64B$1.67B
FY2021, ended Dec 31, 2021$2.04B$1.74B
FY2022, ended Dec 31, 2022$2.11B$1.33B
FY2023, ended Dec 31, 2023$2.34B$1.62B
FY2024, ended Dec 31, 2024$2.49B$2.30B
FY2025, ended Dec 31, 2025$2.67B$2.28B
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$2.64B$2.32B

Cash and cash equivalents

At each fiscal year end, then the latest quarter end.

Show table
Zoetis cash and cash equivalents, annual
PeriodCash and cash equivalents
FY2016, ended Dec 31, 2016$727M
FY2017, ended Dec 31, 2017$1.56B
FY2018, ended Dec 31, 2018$1.60B
FY2019, ended Dec 31, 2019$1.93B
FY2020, ended Dec 31, 2020$3.60B
FY2021, ended Dec 31, 2021$3.48B
FY2022, ended Dec 31, 2022$3.58B
FY2023, ended Dec 31, 2023$2.04B
FY2024, ended Dec 31, 2024$1.99B
FY2025, ended Dec 31, 2025$2.45B
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$1.48B

Total debt

At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.

Show table
Zoetis total debt, annual
PeriodTotal debt
FY2016, ended Dec 31, 2016$4.47B
FY2017, ended Dec 31, 2017$4.95B
FY2018, ended Dec 31, 2018$6.45B
FY2019, ended Dec 31, 2019$6.45B
FY2020, ended Dec 31, 2020$7.20B
FY2021, ended Dec 31, 2021$6.59B
FY2022, ended Dec 31, 2022$7.90B
FY2023, ended Dec 31, 2023$6.57B
FY2024, ended Dec 31, 2024$6.57B
FY2025, ended Dec 31, 2025$9.04B
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$9.05B

Shares outstanding

At each fiscal year end, then the latest quarter end, adjusted for splits. Down 16.0% since FY16.

Show table
Zoetis shares outstanding, annual
PeriodShares outstanding
FY2016, ended Dec 31, 2016492M
FY2017, ended Dec 31, 2017485M
FY2018, ended Dec 31, 2018479M
FY2019, ended Dec 31, 2019475M
FY2020, ended Dec 31, 2020475M
FY2021, ended Dec 31, 2021472M
FY2022, ended Dec 31, 2022463M
FY2023, ended Dec 31, 2023458M
FY2024, ended Dec 31, 2024448M
FY2025, ended Dec 31, 2025422M
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)413M

Buybacks and new shares

By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.

Show table
Zoetis share buybacks and issuance, annual
PeriodBought backPaid to employees
FY2016, ended Dec 31, 2016$300M$37.0M
FY2017, ended Dec 31, 2017$500M$44.0M
FY2018, ended Dec 31, 2018$698M$53.0M
FY2019, ended Dec 31, 2019$626M$67.0M
FY2020, ended Dec 31, 2020$250M$59.0M
FY2021, ended Dec 31, 2021$743M$58.0M
FY2022, ended Dec 31, 2022$1.59B$62.0M
FY2023, ended Dec 31, 2023$1.09B$60.0M
FY2024, ended Dec 31, 2024$1.86B$74.0M
FY2025, ended Dec 31, 2025$3.23B$83.0M
Trailing 12 months to Jun 30, 2026 (through Q2 FY2026)$3.64B$95.0M